The European mesothelioma epidemic

Julian Peto(Institute of Cancer Research), Adriano Decarli(Fondazione IRCCS Istituto Nazionale dei Tumori), Carlo La Vecchia(Mario Negri Institute for Pharmacological Research), Fabio Levi(University Hospital of Lausanne), Eva Negri(Mario Negri Institute for Pharmacological Research)
British Journal of Cancer
January 14, 1999
Cited by 899Open Access
Full Text

Abstract

Projections for the period 1995-2029 suggest that the number of men dying from mesothelioma in Western Europe each year will almost double over the next 20 years, from 5000 in 1998 to about 9000 around 2018, and then decline, with a total of about a quarter of a million deaths over the next 35 years. The highest risk will be suffered by men born around 1945-50, of whom about 1 in 150 will die of mesothelioma. Asbestos use in Western Europe remained high until 1980, and substantial quantities are still used in several European countries. These projections are based on the fit of a simple age and birth cohort model to male pleural cancer mortality from 1970 to 1989 for six countries (Britain, France, Germany, Italy, The Netherlands and Switzerland) which together account for three-quarters of the population of Western Europe. The model was tested by comparing observed and predicted numbers of deaths for the period 1990-94. The ratio of mesothelioma to recorded pleural cancer mortality has been 1.6:1 in Britain but was assumed to be 1:1 in other countries.


Related Papers

No related papers found

Powered by citation graph analysis